Is Continuous Positive Airway Pressure (CPAP) helpful in a newborn with signs of respiratory distress, such as grunting and indrawing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CPAP is Highly Beneficial for Newborns with Grunting and Indrawing

For spontaneously breathing newborns presenting with grunting and indrawing, CPAP should be initiated immediately as it reduces mortality, prevents respiratory failure, and decreases the need for mechanical ventilation. 1

Immediate Clinical Action

Start CPAP at 5-6 cm H₂O pressure immediately for any spontaneously breathing newborn with respiratory distress signs including grunting and indrawing. 2 This applies particularly to preterm infants, where CPAP is the recommended first-line respiratory support rather than routine intubation. 1

Why CPAP Works for These Specific Signs

Understanding Grunting

  • Grunting represents the infant's physiological attempt to generate positive end-expiratory pressure (PEEP) by exhaling against a partially closed glottis to maintain lung volume and prevent alveolar collapse. 1, 3 CPAP mechanically provides this same positive pressure, eliminating the infant's exhausting compensatory effort. 1

Understanding Indrawing (Chest Retractions)

  • Indrawing occurs when more negative intrapleural pressures are required to maintain adequate tidal volumes during states of low lung compliance. 1 CPAP prevents atelectasis by maintaining functional residual capacity, thereby reducing the work of breathing and eliminating the need for these excessive negative pressures. 1, 2

Evidence-Based Outcomes

Mortality Benefit

  • CPAP reduces overall mortality by 47% (RR 0.53) compared to supplemental oxygen alone, with a number needed to treat of 9. 4 This represents moderate-certainty evidence from multiple randomized trials. 4

Prevention of Respiratory Failure

  • CPAP reduces the combined outcome of death or need for mechanical ventilation by 36% (RR 0.64), with a number needed to treat of 6. 4 This means for every 6 infants treated with CPAP, one additional infant avoids death or intubation. 4

Reduced Need for Invasive Ventilation

  • CPAP decreases the need for mechanical ventilation by 28% (RR 0.72), with a number needed to treat of 8. 4 This is particularly important as mechanical ventilation carries risks of airway injury, lung damage, and bronchopulmonary dysplasia. 4

Gestational Age Considerations

Preterm Infants (Strongest Evidence)

  • For preterm infants <30 weeks gestation with respiratory distress, CPAP is specifically recommended over routine intubation. 1 These infants have the highest risk of respiratory distress syndrome due to surfactant deficiency. 2
  • CPAP may reduce death or bronchopulmonary dysplasia in very preterm infants when compared to intubation and positive pressure ventilation. 1

Term Infants (Important Caveat)

  • For term infants, the evidence is insufficient to make a formal recommendation, though CPAP remains reasonable when respiratory distress signs are present. 1 The key distinction is that chest indrawing in infants <2 years can be less specific for pneumonia when observed alone without other severe respiratory distress signs. 1
  • However, when grunting accompanies indrawing, this combination indicates genuine pulmonary disease requiring respiratory support. 1

Critical Implementation Details

When to Escalate Beyond CPAP

  • Prepare for surfactant administration if oxygen requirements exceed 30-40% FiO₂ while on CPAP. 5 This indicates CPAP alone is insufficient.
  • If heart rate remains <60/min despite adequate CPAP, intubation and positive pressure ventilation with chest compressions are indicated. 1

CPAP Settings

  • Initial CPAP pressure should be 5-6 cm H₂O. 2 This provides sufficient positive end-expiratory pressure to prevent alveolar collapse without causing barotrauma. 1

Delivery Methods

  • Nasal prongs or nasal mask are the preferred delivery methods for CPAP in spontaneously breathing infants. 1 Face mask, nasopharyngeal tube, or endotracheal CPAP are alternatives. 4

Important Risk to Monitor

Pneumothorax

  • CPAP increases the risk of pneumothorax 2.5-fold (RR 2.48), with a number needed to harm of 11. 4 This represents low-certainty evidence but requires vigilance. 4
  • Monitor for sudden deterioration, asymmetric breath sounds, or increased oxygen requirements suggesting air leak. 1

Special Populations

Very Low Birth Weight Infants

  • In very low birth weight neonates (<1500g) with respiratory distress, CPAP improved survival to 65.5% compared to 15.4% with standard oxygen therapy alone. 6 This represents a 50% absolute improvement in survival. 6

Resource-Limited Settings

  • Low-cost bubble CPAP systems have demonstrated 27% absolute improvement in survival when treating neonatal respiratory distress in low-resource settings. 6 This makes CPAP a viable intervention even where advanced neonatal intensive care is unavailable. 7, 6

Common Pitfalls to Avoid

  • Do not delay CPAP initiation while waiting for chest X-ray or blood gas results. Clinical signs of grunting and indrawing are sufficient to begin therapy. 1, 3
  • Do not use supplemental oxygen alone as first-line therapy when grunting and indrawing are present. This misses the opportunity to provide mechanical support that addresses the underlying pathophysiology. 4
  • Do not assume chest indrawing in young infants is always benign. When accompanied by grunting, nasal flaring, or severe tachypnea, it indicates significant respiratory compromise requiring intervention. 1, 3
  • Ensure proper fitting of nasal prongs or mask to prevent nasal breakdown. 8 Inappropriately fitted devices can cause nare and nasal septum damage. 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Respiratory Distress Syndrome (RDS) in Newborns

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Neonatal Respiratory Distress Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Respiratory Distress Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Efficacy of a low-cost bubble CPAP system in treatment of respiratory distress in a neonatal ward in Malawi.

Malawi medical journal : the journal of Medical Association of Malawi, 2016

Research

Nursing Care Guidelines for prevention of nasal breakdown in neonates receiving nasal CPAP.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2008

Related Questions

What is the management approach for a 12-month infant with respiratory distress?
What is the best course of treatment for a 5-month-old infant presenting with respiratory distress?
What is the next step in management for a 33-week preterm neonate with respiratory distress, grunting, and chest retraction?
What is the most likely cause of respiratory distress in a 27-week preterm baby born by vaginal delivery?
What is the most appropriate management for a preterm infant born at 29 weeks with Respiratory Distress Syndrome (RDS), presenting with tachypnea, grunting, and nasal flaring?
What is the management approach for a patient presenting with a metallic taste in the mouth suspected of having a brain bleed, possibly due to underlying conditions such as hypertension, anticoagulant use, or previous trauma?
What are the recommendations for an adult patient with type 2 diabetes mellitus (T2DM), weighing 87 kg, Body Mass Index (BMI) of 33, and Hemoglobin A1c (HbA1c) of 10.4%, who stopped taking glipizide (sulfonylurea), an unspecified medication, and metformin (biguanide) for 1 week?
Is amoxicillin (amoxicillin) effective in treating mycoplasma pneumonia?
Is vitamin D2 (ergocalciferol) or vitamin D3 (cholecalciferol) preferred for supplementation in a patient with Chronic Kidney Disease (CKD) stage 3 and elevated Parathyroid Hormone (PTH) levels?
What is the diagnosis and treatment for a patient presenting with white circular lesions in the oropharynx, suspected to be caused by a viral infection?
What is the recommended dose of Augmentin (amoxicillin/clavulanate) for an 8-year-old patient weighing 38.6 kg, using the 600-42.9mg/5ml concentration, for the treatment of mild to moderate or severe infections?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.